Studies have shown that 18F-DCFPyL has higher SUV values and tumor-to-background ratios than 68Ga-PSMA-11 in the diagnosis of prostate cancer primary lesions, especially for the diagnosis of smaller lesions (14). This evidence concerns the gene FOLH1 and neoplasm.